Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on May 27, 2025
Junshi Biosciences Announces Ongericimab’s sNDA Approval in China
GlobeNewswire
·
May 27, 2025
SHANGHAI, May 27, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …
The Australian Creed for Sexual Integrity: Truth in a Time of Compromise
GlobeNewswire
·
May 27, 2025
Sydney, Australia, May 27, 2025 (GLOBE NEWSWIRE) -- At a time when the public discourse has become dominated by progressive ideologies, Christian leaders from around Australia have reaffirmed the Bible’s teachings on sex by launching the Australian Creed …
Final Settlement of Computing Power Loss! KixaMiner Launches Intelligent Chain Scheduling System with Millisecond-Level Optimal Mining Protocol Switching
GlobeNewswire
·
May 27, 2025
London, United Kingdom, May 27, 2025 (GLOBE NEWSWIRE) -- KixaMiner, a pioneer in global compliant cloud mining, announced a major upgrade to its core technical architecture today – the official launch of the "Intelligent Chain Scheduling System" (ICSS). By …
MicroAlgo Inc. Explores Optimization of Quantum Error Correction Algorithms to Enhance Quantum Algorithm Accuracy
GlobeNewswire
·
May 27, 2025
SHENZHEN, May 27, 2025 (GLOBE NEWSWIRE) -- MicroAlgo Inc. Explores Optimization of Quantum Error Correction Algorithms to Enhance Quantum Algorithm Accuracy Shenzhen, May. 27, 2025––MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today …
Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases
GlobeNewswire
·
May 27, 2025
Cash runway extended into 2028; capital proceeds to fund operations through potential 2027 efficacy readout for LX2006 in Friedreich ataxia cardiomyopathy Financing led by Frazier Life Sciences and Janus Henderson Investors with participation from new and …
Adagene to Present at Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 27, 2025
SAN DIEGO and SUZHOU, China, May 27, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chief Strategy Officer, Mickael …
NETCLASS TECHNOLOGY INC. and East China Normal University Sign Cooperation Agreement to Pioneer a New Era of Smart Education
GlobeNewswire
·
May 27, 2025
SHANGHAI and HONG KONG, May 27, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC. (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, has officially …
American Tungsten Corp. Commences Mine Site Preparation and Exploration Work
GlobeNewswire
·
May 27, 2025
Vancouver, BC, May 27, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that the Company has commenced construction and building work to support exploration …
ZA Miner Launches New 3-Day Short-Term Cloud Mining Contracts for May 2025 — Built for XRP Holders Seeking Fast Passive Returns
GlobeNewswire
·
May 27, 2025
London, United Kingdom, May 27, 2025 (GLOBE NEWSWIRE) -- ZA Miner, a global leader in crypto cloud mining, today announced the launch of new 3-day short-term cloud mining contracts designed specifically for Ripple (XRP) holders looking to generate fast and …
Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Population Against Relevant, Immune-Evasive SARS-CoV-2…
GlobeNewswire
·
May 27, 2025
CANOPY assessed pemivibart safety and tolerability, antiviral immunobridging, and exploratory efficacy against COVID-19, and is the only clinical trial of an authorized or approved COVID-19 monoclonal antibody or vaccine with placebo-controlled clinical …
BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
RESEARCH TRIANGLE PARK, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences: Jefferies Global Healthcare Conference in New York on Wednesday, …
Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
BOSTON, May 27, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 46th Annual …
REPEAT – Koryx Copper Announces Further Highly Encouraging Drill Results at the Haib Copper Project, Southern Namibia
GlobeNewswire
·
May 27, 2025
Highlights • Completed 29 drill holes out of a planned 37 holes in Phase 2 for 8,647m of diamond drilling. • Many results received have higher Cu grade than average MRE over large intercepts and include: • HM62: 572m @ 0.33% Cu (0 to 572m …
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
GlobeNewswire
·
May 27, 2025
Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations Will Leverage Deep Pharma Services Expertise as Leader of Lifecore’s Sales Organization Focused on …
Emerita Achieves 81.5% Gold Recovery for 27% Improvement Over Previous Metallurgical Testing for IBW Project
GlobeNewswire
·
May 27, 2025
TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX – V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) is pleased to provide updated results on its metallurgical testing program (the “Program”) for its wholly-owned Iberian …
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
BOSTON and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or …
NewGen Announces Strategic Expansion with Services Tailored for Indian Medical Tourists
GlobeNewswire
·
May 27, 2025
BANGKOK, May 27, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that …
XRP News: Buy $XDX By XenDex On XRP Ledger As Ripple Acquires Circle While Volatility Shares Launches XRPI Futures ETF
GlobeNewswire
·
May 27, 2025
SYDNEY, May 27, 2025 (GLOBE NEWSWIRE) -- XenDex is moving to end its presale in about 24 hours, and top crypto analysts have confirmed that the $XDX token with its utility, has the potential of attaining various all time high and great profits for its …
PDD Holdings Announces First Quarter 2025 Unaudited Financial Results
GlobeNewswire
·
May 27, 2025
DUBLIN and SHANGHAI, May 27, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Total …
TRX Gold Files NI 43-101 Preliminary Economic Assessment for the Buckreef Gold Project
GlobeNewswire
·
May 27, 2025
TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- RX Gold Corporation (TSX: TRX) (NYSE American: TRX) (the “Company” or “TRX Gold”) has filed on SEDAR+ a Technical Report prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral …